Trial Profile
Retrospective, single-center observational study investigating safety and efficacy of rituximab combined with methylprednisolone pulse therapy (MPT) in children with steroid-resistant nephrotic syndrome (SRNS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Nephrotic syndrome
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2015 New trial record